Ensuring compliance, strengthening resilience: Strategies fo...
With people’s health and lives at stake, maintaining a resilient pharmaceutical supply chain to ensure the timely delivery of life-saving medication is critical.
Technology working as the puzzle piece to bring better outco...
While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about
California to sell state-branded Narcan generic to cut costs
California has said it will start selling its own generic version of overdose reversal agent naloxone in another example of the use of government-level purchasing power to
Prime editing comes of age as FDA clears human trials
Prime Medicine has been given the go-ahead by the FDA for the first human trial of its prime editing technology, which promises to deliver one-shot therapies for a range o
BMS, J&J challenges to Medicare negotiations are thrown out
In another setback for the pharma industry, a US federal judge has rejected a bid to overturn the Medicare pricing negotiation brought by Bristol-Myers Squibb and Johnson
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
FT US PHARMA AND BIOTECH SUMMIT
2024 is a pivotal year for the US healthcare sector.
2nd ADC Toxicity Summit 2024
Improving Prediction & Translation of ADC Toxicities to Drive More Tolerable ADCs Successfully Into & Through Clinical Development
15th World Bispecific Summit 2024
Radically Optimize Bi, Tri & Multispecific Antibodies to Enhance Target Discovery, Mechanistic Diversity & Clinical Translation to Maximize the Therapeutic Index & Enhance Combi
9th Microbiome Movement Drug Development Summit
The Home of Accelerating Microbial-Based Drug Development
The PM Society – Giving Back
The PM Society is a not-for-profit organisation with 40 years of Giving Back.